These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1001244)

  • 21. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.
    Chouinard G; Annable L; Turnier L; Holobow N; Szkrumelak N
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S114-21. PubMed ID: 8306241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal study of the effect, tolerance and undesired side effects of injection haloperidol decanoate applied in different psychiatric indications.
    Zbytovský J; Zapletálek M
    Act Nerv Super (Praha); 1989 Dec; 31(4):266-7. PubMed ID: 2638106
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB; Swigar ME; Jatlow PI; Goicoechea N
    J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
    Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
    J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients.
    Tesar GE; Murray GB; Cassem NH
    J Clin Psychopharmacol; 1985 Dec; 5(6):344-7. PubMed ID: 4067002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
    Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
    Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Haloperidol. Plasma monitoring and hormonal effects of treatment].
    Goyot C; Debray Q; Dugas M; Guay C; Giraud J; Grenier J
    Pathol Biol (Paris); 1985 Dec; 33(10):999-1004. PubMed ID: 2937009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J; Glitschka A; Müller K
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract]   [Full Text] [Related]  

  • 34. Acutely disturbed psychotic patients treated with parenteral haloperidol.
    Firling RJ
    IMJ Ill Med J; 1978 Feb; 153(2):117. PubMed ID: 24024
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapid control of psychotic excitement states with intramuscular haloperidol.
    Sangiovanni F; Taylor MA; Abrams R; Gaztanaga P
    Am J Psychiatry; 1973 Oct; 130(10):1155-6. PubMed ID: 4728914
    [No Abstract]   [Full Text] [Related]  

  • 36. [Perspectives of adequate individual doses].
    Maerz JC
    Acta Psiquiatr Psicol Am Lat; 1979 Mar; 25(1):69-73. PubMed ID: 547686
    [No Abstract]   [Full Text] [Related]  

  • 37. High doses of Haldol in the treatment of 5 young schizophrenics in a therapeutic community.
    Moinet A; Van Nuffel D
    Acta Psychiatr Belg; 1976; 76(1):149-56. PubMed ID: 970183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient titration with intramuscular haloperidol as an alternative to psychiatric hospitalization.
    Ingall MA; Farber BL; Kuppe JV; Silveira AP
    R I Med J (1976); 1979 Nov; 62(11):437-42. PubMed ID: 293841
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical experience with low doses of haloperidol in the treatment of neuroses.
    Preiningerová O; Zapletálek M; Kudrnová K; Svejkovská J
    Act Nerv Super (Praha); 1979 Oct; 21(3):136. PubMed ID: 517076
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous haloperidol in the treatment of acute psychosis.
    Carter JG
    Am J Psychiatry; 1986 Oct; 143(10):1316-7. PubMed ID: 3766801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.